<p>在 Google 搜索和 AI 回答中查看更多来自 StockTitan 的信息。将 StockTitan 添加为首选来源 · 打开 Google</p>
<p>在 Google 上添加</p>
<p>伦敦 --（商业新闻）--LivaNova PLC（纳斯达克：LIVN），一家市场领先的医疗技术公司，今天宣布任命 Anne Liddy 为首席法律官，任命于 8 月 31 日生效。Liddy 将负责公司的全球法律和合规职能，并担任执行领导团队成员。</p>
<p>Liddy 拥有超过二十年的经验，为全球医疗保健和生命科学公司提供复杂的法律、监管、并购和合规事务的咨询。她在加入 LivaNova 之前曾在 Hologic, Inc.工作，最近担任总法律顾问，领导全球法律组织，并为高级领导层和董事会提供关键业务、交易和合规倡议的建议。</p>
<p>“Anne 是一位成就卓越的高管，拥有指导组织应对复杂监管和商业环境的丰富经验，” LivaNova 首席执行官 Vladimir Makatsaria 表示。“她深厚的医疗保健专业知识和协作、战略的领导风格将在我们推进核心业务和创新议程，以为患者、客户和股东创造长期价值的过程中发挥重要作用。”</p>
<p>在担任总法律顾问之前，Liddy 在 Hologic 的法律组织中担任了越来越多责任的领导职位，负责商业、知识产权、雇佣、合规和诉讼事务。她职业生涯早期曾在辉瑞公司担任企业法律顾问，支持消费者医疗保健业务。她的法律职业生涯始于波士顿的 Ropes &amp; Gray LLP。</p>
<p>“我很荣幸在这个关键时刻加入 LivaNova，因为公司正在利用其势头并推动其战略，以为全球客户提供有意义的影响，” Liddy 说。“LivaNova 致力于通过创新改善患者生活，我期待与领导团队合作，支持公司的战略优先事项，推进其全球合规框架，并帮助推动可持续增长。”</p>
<p>Liddy 拥有霍利十字学院的文学学士学位和康奈尔大学法学院的法学博士学位。</p>
<p><strong>关于 LivaNova</strong></p>
<p>LivaNova PLC 是一家全球医疗技术公司，拥有近五十年的经验和改变人们生活轨迹的愿景。通过在特定神经和心脏疾病领域的巧妙医疗解决方案，LivaNova 努力点燃患者的转机。公司总部位于伦敦，拥有约 3300 名员工，并在 100 多个国家开展业务，服务于全球患者、医疗专业人员和医疗系统。有关更多信息，请访问 www.livanova.com。</p>
<p><strong>安全港声明</strong></p>
<p>本新闻稿包含有关公司目标、信念、期望、战略、目标、计划、基本假设和其他不一定基于历史事实的 “前瞻性声明”。这些声明包括但不限于关于公司高管领导变动的声明。实际事件可能因各种因素而与我们的前瞻性声明中所指示的情况有实质性差异，包括公司最近的 10-K 表格年报第 1A 项中列出的因素，以及季度报告 10-Q 表格和当前报告 8-K 表格中包含的任何风险因素。LivaNova 没有义务更新本新闻稿中包含的信息，以反映随后发生的事件或情况。</p>
<p><img src="https://imageproxy.pbkrs.com/https://cts.businesswire.com/ct/CT/query-ZGlzdHJvPW54JmlkPWJ3bmV3cyZsYW5nPWVuJnNpZD1hY3FyOCZzdHk9MjAyNjA2MDU4Nzk0ODlyMQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://cts.businesswire.com/ct/CT/query-ZGlzdHJvPW54JmlkPWJ3bmV3cyZsYW5nPWVuJnNpZD1hY3FyOCZzdHk9MjAyNjA2MDU4Nzk0ODlyMQ"/></p>
<p>在 businesswire.com 查看源版本：https://www.businesswire.com/news/home/20260605879489/en/</p>
<p>LivaNova 投资者关系和媒体联系人</p>
<p>+1 281-895-2382</p>
<p><strong>Briana Gotlin</strong></p>
<p>投资者关系副总裁</p>
<p>InvestorRelations@livanova.com</p>
<p><strong>Deanna Wilke</strong></p>
<p>企业传播副总裁</p>
<p>Corporate.Communications@livanova.com</p>
<p>来源：LivaNova PLC</p>

LIVN

<p>LivaNova PLC（纳斯达克代码：LIVN）宣布任命 Anne Liddy 为首席法律官，任命将于 8 月 31 日生效。Liddy 将负责全球法律和合规职能，并加入执行领导团队。她在 Hologic, Inc.拥有超过二十年的经验，曾担任总法律顾问。首席执行官 Vladimir Makatsaria 赞扬了她在医疗保健监管事务方面的专业知识，表示她的领导将支持公司的战略优先事项和可持续增长</p>

<p>See more from StockTitan in Google Search and AI answers.Adds StockTitan as a preferred source · opens Google</p>
<div class="lb-trans"><p>在 Google 搜索和 AI 回答中查看更多来自 StockTitan 的信息。将 StockTitan 添加为首选来源 · 打开 Google</p>
</div><p>Add on Google</p>
<div class="lb-trans"><p>在 Google 上添加</p>
</div><p>LONDON--(BUSINESS WIRE)--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced the appointment of Anne Liddy as Chief Legal Officer, effective August 31. Liddy will oversee the Company’s global legal and compliance function and serve as a member of the Executive Leadership Team.</p>
<div class="lb-trans"><p>伦敦 --（商业新闻）--LivaNova PLC（纳斯达克：LIVN），一家市场领先的医疗技术公司，今天宣布任命 Anne Liddy 为首席法律官，任命于 8 月 31 日生效。Liddy 将负责公司的全球法律和合规职能，并担任执行领导团队成员。</p>
</div><p>Liddy brings more than two decades of experience advising global healthcare and life sciences companies on complex legal, regulatory, M&amp;A, and compliance matters. She joins LivaNova from Hologic, Inc., where she most recently served as General Counsel, leading a global legal organization and advising senior leadership and the Board of Directors on critical business, transactional, and compliance initiatives.</p>
<div class="lb-trans"><p>Liddy 拥有超过二十年的经验，为全球医疗保健和生命科学公司提供复杂的法律、监管、并购和合规事务的咨询。她在加入 LivaNova 之前曾在 Hologic, Inc.工作，最近担任总法律顾问，领导全球法律组织，并为高级领导层和董事会提供关键业务、交易和合规倡议的建议。</p>
</div><p>“Anne is a highly accomplished executive with an established record of achievement, guiding organizations through complex regulatory and business environments,” said Vladimir Makatsaria, Chief Executive Officer of LivaNova. “Her deep healthcare expertise and collaborative, strategic leadership style will be instrumental as we advance our core business and innovation agenda to deliver long-term value for patients, customers, and shareholders.”</p>
<div class="lb-trans"><p>“Anne 是一位成就卓越的高管，拥有指导组织应对复杂监管和商业环境的丰富经验，” LivaNova 首席执行官 Vladimir Makatsaria 表示。“她深厚的医疗保健专业知识和协作、战略的领导风格将在我们推进核心业务和创新议程，以为患者、客户和股东创造长期价值的过程中发挥重要作用。”</p>
</div><p>Prior to her role as General Counsel, Liddy held leadership positions of increasing responsibility within Hologic’s legal organization, with oversight spanning commercial, intellectual property, employment, compliance, and litigation matters. Earlier in her career, she served as Corporate Counsel at Pfizer, Inc., supporting the consumer healthcare business. She began her legal career at Ropes &amp; Gray LLP in Boston.</p>
<div class="lb-trans"><p>在担任总法律顾问之前，Liddy 在 Hologic 的法律组织中担任了越来越多责任的领导职位，负责商业、知识产权、雇佣、合规和诉讼事务。她职业生涯早期曾在辉瑞公司担任企业法律顾问，支持消费者医疗保健业务。她的法律职业生涯始于波士顿的 Ropes &amp; Gray LLP。</p>
</div><p>“I am honored to join LivaNova at this defining moment as the Company builds on its momentum and drives its strategy forward to provide meaningful impact for customers worldwide,” Liddy said. “LivaNova has a strong commitment to improving patients’ lives through innovation, and I look forward to partnering with the leadership team to support the Company’s strategic priorities, advance its global compliance framework, and help drive sustainable growth.”</p>
<div class="lb-trans"><p>“我很荣幸在这个关键时刻加入 LivaNova，因为公司正在利用其势头并推动其战略，以为全球客户提供有意义的影响，” Liddy 说。“LivaNova 致力于通过创新改善患者生活，我期待与领导团队合作，支持公司的战略优先事项，推进其全球合规框架，并帮助推动可持续增长。”</p>
</div><p>Liddy holds a Bachelor of Arts degree from the College of the Holy Cross and a Juris Doctor from Cornell University Law School.</p>
<div class="lb-trans"><p>Liddy 拥有霍利十字学院的文学学士学位和康奈尔大学法学院的法学博士学位。</p>
</div><p><strong>About LivaNova</strong></p>
<div class="lb-trans"><p><strong>关于 LivaNova</strong></p>
</div><p>LivaNova PLC is a global medical technology company built on nearly five decades of experience and a vision to change the trajectory of lives for a new day. Through ingenious medical solutions in select neurological and cardiac conditions, LivaNova strives to ignite patient turnarounds. Headquartered in London, with approximately 3,300 employees and a presence in more than 100 countries, LivaNova serves patients, healthcare professionals, and healthcare systems worldwide. For more information, please visit www.livanova.com.</p>
<div class="lb-trans"><p>LivaNova PLC 是一家全球医疗技术公司，拥有近五十年的经验和改变人们生活轨迹的愿景。通过在特定神经和心脏疾病领域的巧妙医疗解决方案，LivaNova 努力点燃患者的转机。公司总部位于伦敦，拥有约 3300 名员工，并在 100 多个国家开展业务，服务于全球患者、医疗专业人员和医疗系统。有关更多信息，请访问 www.livanova.com。</p>
</div><p><strong>Safe Harbor Statement</strong></p>
<div class="lb-trans"><p><strong>安全港声明</strong></p>
</div><p>This news release contains “forward-looking statements” concerning the Company’s goals, beliefs, expectations, strategies, objectives, plans, underlying assumptions, and other statements that are not necessarily based on historical facts. These statements include, but are not limited to, statements regarding changes to the Company’s executive leadership. Actual events may differ materially from those indicated in our forward-looking statements as a result of various factors, including those factors set forth in Item 1A of the Company’s most recent Annual Report on Form 10-K, as supplemented by any risk factors contained in Quarterly Reports on Form 10-Q and Current Reports on Form 8-K. LivaNova undertakes no obligation to update the information contained in this press release to reflect subsequently occurring events or circumstances.</p>
<div class="lb-trans"><p>本新闻稿包含有关公司目标、信念、期望、战略、目标、计划、基本假设和其他不一定基于历史事实的 “前瞻性声明”。这些声明包括但不限于关于公司高管领导变动的声明。实际事件可能因各种因素而与我们的前瞻性声明中所指示的情况有实质性差异，包括公司最近的 10-K 表格年报第 1A 项中列出的因素，以及季度报告 10-Q 表格和当前报告 8-K 表格中包含的任何风险因素。LivaNova 没有义务更新本新闻稿中包含的信息，以反映随后发生的事件或情况。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://cts.businesswire.com/ct/CT/query-ZGlzdHJvPW54JmlkPWJ3bmV3cyZsYW5nPWVuJnNpZD1hY3FyOCZzdHk9MjAyNjA2MDU4Nzk0ODlyMQ" alt="" original-src="https://cts.businesswire.com/ct/CT?id=bwnews&amp;sty=20260605879489r1&amp;sid=acqr8&amp;distro=nx&amp;lang=en"/></p>
<p>View source version on businesswire.com: https://www.businesswire.com/news/home/20260605879489/en/</p>
<div class="lb-trans"><p>在 businesswire.com 查看源版本：https://www.businesswire.com/news/home/20260605879489/en/</p>
</div><p>LivaNova Investor Relations and Media Contacts</p>
<div class="lb-trans"><p>LivaNova 投资者关系和媒体联系人</p>
</div><p>+1 281-895-2382</p>
<div class="lb-trans"><p>+1 281-895-2382</p>
</div><p><strong>Briana Gotlin</strong></p>
<div class="lb-trans"><p><strong>Briana Gotlin</strong></p>
</div><p>VP, Investor Relations</p>
<div class="lb-trans"><p>投资者关系副总裁</p>
</div><p>InvestorRelations@livanova.com</p>
<div class="lb-trans"><p>InvestorRelations@livanova.com</p>
</div><p><strong>Deanna Wilke</strong></p>
<div class="lb-trans"><p><strong>Deanna Wilke</strong></p>
</div><p>VP, Corporate Communications</p>
<div class="lb-trans"><p>企业传播副总裁</p>
</div><p>Corporate.Communications@livanova.com</p>
<div class="lb-trans"><p>Corporate.Communications@livanova.com</p>
</div><p>Source: LivaNova PLC</p>
<div class="lb-trans"><p>来源：LivaNova PLC</p>
</div>

LivaNova 任命 Anne Liddy 为首席法律官 | LIVN 股票新闻